260
Participants
Start Date
June 19, 2019
Primary Completion Date
January 12, 2024
Study Completion Date
January 12, 2024
Ascendis Pharma Investigational Site, Dublin
Ascendis Pharma Investigational Site, Lausanne
Ascendis Pharma Investigational Site, Vitoria-Gasteiz
Ascendis Pharma Investigational Site, Auckland
Ascendis Pharma Investigational Site, Copenhagen
Ascendis Pharma Investigational Site, Coimbra
Ascendis Pharma Investigational Site, Parkville
Ascendis Pharma Investigational Site, Linz
Ascendis Pharma Investigational Site, Esplugues de Llobregat
Ascendis Pharma Investigational Site, Berlin
Ascendis Pharma Investigational Site, Buffalo
Ascendis Pharma Investigational Site, Wilmington
Ascendis Pharma Investigational Site, Shanghai
Ascendis Pharma Investigational Site, Milan
Ascendis Pharma Investigational Site, Madrid
Ascendis Pharma Investigational Site, Madison
Ascendis Pharma Investigational Site, Saint Paul
Ascendis Pharma Investigational Site, Columbia
Ascendis Pharma Investigational Site, Little Rock
Ascendis Pharma Investigational Site, Paris
Ascendis Pharma Investigational Site, Houston
Ascendis Pharma Investigational Site, Aurora
Ascendis Pharma Investigational Site, Oakland
Ascendis Pharma Investigational Site, Seattle
Ascendis Pharma Investigational Site, Beijing
Ascendis Pharma Investigational Site, Hangzhou
Ascendis Pharma Investigational Site, Wuhan
Ascendis Pharma Investigational Site, Guangzhou
Ascendis Pharma Investigational Site, Shenzhen
Ascendis Pharma Investigational Site, Edmonton
Ascendis Pharma Investigational Site, Ottawa
Ascendis Pharma Investigational Site, Montreal
Ascendis Pharma Investigational Site, Barcelona
Ascendis Pharma Investigational Site, Glasgow
Ascendis Pharma Investigational Site, London
Lead Sponsor
Ascendis Pharma A/S
INDUSTRY